Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
CorrectionErratum

Correction to “Pharmacogenomic Next-Generation DNA Sequencing: Lessons from the Identification and Functional Characterization of Variants of Unknown Significance in CYP2C9 and CYP2C19”

Drug Metabolism and Disposition February 2020, 48 (2) 85; DOI: https://doi.org/10.1124/dmd.118.084269err
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

In the above article [Devarajan S, Moon I, Ho M-F, Larson NB, Neavin DR, Moyer AM, Black JL, Bielinski SJ, Scherer SE, Wang L, Weinshilboum RM, and Reid JM (2019) Drug Metab Dispos 47 (4), 425-435; DOI:https://doi.org/10.1124/dmd.118.084269], a few mistakes were accidentally introduced during the preparation and review of the manuscript.

First, Authorship line, Dr. Sandhya Devarajan was incorrectly listed as the primary author for this work. Dr. Sandhya Devarajan and Ms. Irene Moon contributed equally to this work and now listed as co-first authors for the manuscript and a footnote added.

Second, Table 2, on page 428, in the 4th row titled ‘Gene’, the column ‘rsID’ should list ‘Not present’ instead of ‘rs549167718’; column ’Validation’ should be empty instead of ‘2’; column ‘gnomAD Data Bank (Minor Allele Frequency)’ should be ‘Not recorded’ instead of ‘4.099E-06a’. In the 5th row titled ‘Gene’, the column ‘gnomAD Data Bank (Minor Allele Frequency)’ should have ‘a’ footnote reference instead of ‘b’. In the footnote section below the table, footnote ‘awithout frameshift’ should be deleted and footnote ‘b’ should be changed to ‘a’. The corrected table is provided below

View this table:
  • View inline
  • View popup
Table 2

Data search results for CYP2C9 and CYP2C19 variants in gnomAD data bank.

The data base search results were obtained from gnomAD (http://gnomad.broadinstitute.org/) and dbSNP (https://www.ncbi.nlm.nih.gov/projects/SNP/) in August 2018.

Third, Results Section on page 428, right column, line seven ‘229C>A and 709G>C’ should be ‘229C>A, 707delA and 709G>C’. On page 429, left column, line 2, ‘three of the identified CYP2C19 variants (229C>A, 709G>C and 801C>T)’ should be ‘five of the identified CYP2C9 variants (218C>T, 343A>C, 707delA, 707_709delinsCC and 791T>C). On page 429, right column, line 2, ‘(65A>G, 337 G>A, 578A>G and 815A>G) should be (518C>T, 556C>T, 557G>A and 815A>G).

Fourth, Table 4, on page 433, line one under the title, ‘518C>CT, 556C>CT’ should be ‘518C>T, 556C>T’.

The HTML and PDF versions of the article have been corrected.

The authors regret these errors and apologize for any inconvenience this may have caused.

  • Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 48 (2)
Drug Metabolism and Disposition
Vol. 48, Issue 2
1 Feb 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Correction to “Pharmacogenomic Next-Generation DNA Sequencing: Lessons from the Identification and Functional Characterization of Variants of Unknown Significance in CYP2C9 and CYP2C19”
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
CorrectionErratum

Correction to “Pharmacogenomic Next-Generation DNA Sequencing: Lessons from the Identification and Functional Characterization of Variants of Unknown Significance in CYP2C9 and CYP2C19”

Drug Metabolism and Disposition February 1, 2020, 48 (2) 85; DOI: https://doi.org/10.1124/dmd.118.084269err

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
CorrectionErratum

Correction to “Pharmacogenomic Next-Generation DNA Sequencing: Lessons from the Identification and Functional Characterization of Variants of Unknown Significance in CYP2C9 and CYP2C19”

Drug Metabolism and Disposition February 1, 2020, 48 (2) 85; DOI: https://doi.org/10.1124/dmd.118.084269err
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Correction to “Microbial Metabolites as Ligands to Xenobiotic Receptors: Chemical Mimicry as Potential Drugs of the Future”
  • Correction to “Dimethandrolone, a Potential Male Contraceptive Pill, is Primarily Metabolized by the Highly Polymorphic UDP-Glucuronosyltransferase 2B17 Enzyme in Human Intestine and Liver”
  • Correction to “Identification of 5-Hydroxycotinine in the Plasma of Nicotine-Treated Mice: Implications for Cotinine Metabolism and Disposition in Vivo”
Show more Erratum

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics